Literature DB >> 3075350

The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria.

.   

Abstract

30 pairs of patients with complicated Plasmodium falciparum malaria (with anaemia, hyperpyrexia, jaundice or more than 5% of erythrocytes parasitized) were studied. Patients with cerebral signs and symptoms were excluded. One group of patients was treated with oral mefloquine (750 mg) and artemether (600 mg by injection, 200 mg initially and 100 mg every 12 h). The second group of patients was treated with quinine (10 mg/kg orally every 8 h for 7 d). All patients were admitted to hospital for 7 d and examined subsequently on days 14, 21 and 28. All those treated with mefloquine plus artemether survived and their parasite clearance time and fever clearance time were significantly shorter than those of patients receiving quinine. 2 patients treated with quinine died. There was no recrudescence in any patient of either group.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3075350     DOI: 10.1016/0035-9203(88)90187-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria.

Authors:  K Win; M Than; Y Thwe
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

2.  Artemether for severe malaria.

Authors:  Ekpereonne B Esu; Emmanuel E Effa; Oko N Opie; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

Review 3.  Origin and Spread of Evolving Artemisinin-Resistant Plasmodium falciparum Malarial Parasites in Southeast Asia.

Authors:  Matthew R Hassett; Paul D Roepe
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

Review 4.  Artemisinin derivatives for treating severe malaria.

Authors:  H M McIntosh; P Olliaro
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial.

Authors:  Jane Ruth Aceng; Justus S Byarugaba; James K Tumwine
Journal:  BMJ       Date:  2005-02-12

Review 6.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

Authors:  S R Meshnick; T E Taylor; S Kamchonwongpaisan
Journal:  Microbiol Rev       Date:  1996-06

Review 7.  Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.

Authors:  P J de Vries; T K Dien
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

Review 8.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

9.  Neurotoxicity of artemisinin analogs in vitro.

Authors:  D L Wesche; M A DeCoster; F C Tortella; T G Brewer
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 10.  Artemether for severe malaria.

Authors:  Ekpereonne Esu; Emmanuel E Effa; Oko N Opie; Amirahobu Uwaoma; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2014-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.